Drug Pricing Under the Trump Administration

Drug Pricing Under the Trump Administration

Recently, President Donald Trump met with executives from the Pharmaceutical Research and Manufacturers of America (PhRMA) to discuss issues in...

Return of the CEO

Return of the CEO

In the sixth episode of the Drug Price Wars, we get to revisit the CEO of Turing Pharmaceuticals who has...

FDA Approval Process: The case of Rosiglitazone (Avandia)

FDA Approval Process: The case of Rosiglitazone (Avandia)

Rosiglitazone (Avandia) is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding...

Attention-driven choice: FDA vs. Compounding pharmacies

Attention-driven choice: FDA vs. Compounding pharmacies

In October of 2012, the Food and Drug Administration announced a nationwide recall of sterile products compounded by the New...

All original content on these pages is fingerprinted and certified by Digiprove